Published: 01-11-2011 00:00 | Updated: 26-11-2013 10:29
Aspirin reduces the incidence of cancer in carriers of hereditary colorectal cancer
[NEWS 1 November 2011] Professor Annika Lindblom at the Department of Molecular Medicine and Surgery is co-author in a study that shows that regular use of aspirin substantially reduces the incidence of cancer in carriers of hereditary colorectal cancer.
Publication in the Lancet
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
Lancet. 2011 Oct 27. [Epub ahead of print]